Innate Pharma S.A.

IPHA · NASDAQ
Analyze with AI
$1.84−$0.045 (−2.39%)
At close:Dec 16, 2025, 7:07 PM UTC
$1.83−$0.005 (−0.27%)
After hours:Dec 16, 2025, 7:07 PM UTC
P/E TTM-3
P/B TTM26.89
P/S TTM11.82
Dividend Yield0%
EPS-$0.64
Beta0.512
Valuation
PEG Ratio-0.31
FCF Yield-27.63%
EV / EBITDA-2.55
More On Valuation »
Quality
ROIC-64.75%
Gross Margin-243.65%
Cash Conv. Ratio0.89
More On Quality »
Growth
Revenue 3Y CAGR-39.74%
FCF Growth79.13%
More On Growth »
Safety
Net Debt / EBITDA0.55
Interest Coverage-12.98
More On Safety »
Efficiency
Inventory Turnover0.00
Cash Conv. Cycle-27.77
More On Efficiency »

Innate Pharma S.A. (IPHA) stock FAQs

Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.

What is Innate Pharma S.A. (IPHA) stock price today?

As of Dec 16, 2025, 7:07 PM UTC, Innate Pharma S.A. (IPHA) stock is trading at $1.84. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date IPHA stock quotes for informed trading decisions.

What is Innate Pharma S.A.'s market capitalization?

Innate Pharma S.A. (IPHA) has a market capitalization of approximately $154.6M. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Innate Pharma S.A.'s size relative to other companies in the USD market. The market cap figure updates automatically as the IPHA stock price changes.

What is the 52-week range for Innate Pharma S.A. stock?

Innate Pharma S.A. (IPHA) stock has traded in a 52-week range of $1.60 — $2.63. The 52-week range shows the highest and lowest prices at which IPHA traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Innate Pharma S.A. stock price to this range provides context for recent price action.

How much trading volume does Innate Pharma S.A. stock have?

Innate Pharma S.A. (IPHA) stock recently traded approximately 31.2K shares. Trading volume indicates market liquidity and investor interest in IPHA. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Innate Pharma S.A. stock.

Does Innate Pharma S.A. pay dividends to shareholders?

Yes, Innate Pharma S.A. (IPHA) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Innate Pharma S.A. stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is Innate Pharma S.A.'s intraday price range?

Today, Innate Pharma S.A. (IPHA) stock has traded in a range of $1.81 — $1.88. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring IPHA's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get Innate Pharma S.A. stock data?

AlphaPilot sources real-time IPHA stock quotes, fundamental financial data, and historical price charts for Innate Pharma S.A. from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Innate Pharma S.A. stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of IPHA stock performance.